Roger Bate

Last updated

Roger Bate is a British educated economist who has held a variety of positions in free market oriented organizations. His work focuses on solving the problem of counterfeit and substandard medicines, particularly those in the developing world. He also works on US and international aid policy, performance of aid organisations, and health policy in developing countries, particularly with regard to malaria control and the use of DDT. [1] He consulted for the tobacco industry in the mid-'90s, though the extent of this work is disputed. [2] [3] He is currently a fellow of the American Enterprise Institute and the Institute of Economic Affairs, and he was on the board of directors of Africa Fighting Malaria.

Contents

Early life and education

Bate was a tennis coach from 1984 to 1986 and between 1986 and 1989 worked as a research analyst for Warburg Securities and Charles Stanley Stockbrokers. [4] Bate attended Thames Valley University and 1n 1992 graduated with a BA in economics, then University College, London graduating with a MSc in Environmental Resource management in 1993. [4] He studied economics at the University of Cambridge and in 1994 obtained an MPhil in land economy. [4]

Career

He later worked for the Institute of Economic Affairs.In 1993, Bate worked for the Institute of Economic Affairs, a British free market think tank, and founded the Environmental Unit. In 1994, he started the European Science and Environment Forum (ESEF). [1]

In 1996, Bate approached R.J. Reynolds Tobacco Company for a grant of £50,000 to fund a book on risk, containing a chapter on passive smoking, (i.e. "second hand smoke") but the grant request was denied.[ citation needed ] According to internal industry documents the Tobacco Institute was nonetheless "involved in" the publication of the book. [5] That same year he wrote the article "Is Nothing Worse Than Tobacco?" for The Wall Street Journal , and later ESEF published What Risk? Science, Politics and Public Health, edited by Bate, which included a chapter on passive smoking. After the publication of this chapter, according to Bate, he undertook a brief period consulting for the Philip Morris corporation. He then approached Philip Morris seeking funding for a project on DDT and malaria. [2] [6]

Genetic engineering

Bate is joint author, with Julian Morris of Fearing Food: Risk, Health and Environment. The IEA website describes the book in the following way: "In the latest ESEF book, Fearing Food, new agricultural and food technologies, including genetic engineering, are shown to be generally beneficial both to health and to the environment." (Fearing Food was published by Butterworth-Heinemann in September 1999). He was also a presenter on the BBC2 program Organic Food: The Modern Myth.

Counterfeit drugs

Bate's work focuses on the prevalence of counterfeit anti-malarials and other pharmaceuticals in Africa [7] [8] and strategies by which rich and poor nations can work together to stop the trade of counterfeits. His original research has been published by the National Bureau of Economic Research, [9] the Journal of Health Economics, [10] and PLoS Medicine. [11] AEI Press will publish his book Phake: The Deadly World of Falsified and Substandard Medicines in May 2011. The book explores the underground trade in illegal medicines, provides a firsthand account of the illegal industry, and offers academic and policy analysis. Prior to Phake, AEI Press published his book Making a Killing: The Deadly Implications of the Counterfeit Drug Trade in May 2008. In Making a Killing, Bate calls for stronger policing resources, harsher penalties for counterfeiters, widespread public education and consumer vigilance to deal with the proliferation of counterfeit drugs.

Bate distinguishes between approved generic drugs and what he calls "pseudo-generics." These are drugs approved as generic versions of proprietary drugs by bodies such as the World Health Organization and the Bill and Melinda Gates Foundation, but which, according to Bate, have not been adequately tested for efficacy. [12]

Funding

Bate's work has been funded by the Legatum Institute, which is affiliated with Legatum Capital. [1] [13] He has also received funding from Novartis. [14]

Positions held

Related Research Articles

<span class="mw-page-title-main">DDT</span> Organochloride known for its insecticidal properties

Dichlorodiphenyltrichloroethane, commonly known as DDT, is a colorless, tasteless, and almost odorless crystalline chemical compound, an organochloride. Originally developed as an insecticide, it became infamous for its environmental impacts. DDT was first synthesized in 1874 by the Austrian chemist Othmar Zeidler. DDT's insecticidal action was discovered by the Swiss chemist Paul Hermann Müller in 1939. DDT was used in the second half of World War II to limit the spread of the insect-borne diseases malaria and typhus among civilians and troops. Müller was awarded the Nobel Prize in Physiology or Medicine in 1948 "for his discovery of the high efficiency of DDT as a contact poison against several arthropods". The WHO's anti-malaria campaign of the 1950s and 1960s relied heavily on DDT and the results were promising, though there was a resurgence in developing countries afterwards.

<i>Silent Spring</i> 1962 book by Rachel Carson on the environment

Silent Spring is an environmental science book by Rachel Carson. Published on September 27, 1962, the book documented the environmental harm caused by the indiscriminate use of pesticides. Carson accused the chemical industry of spreading disinformation, and public officials of accepting the industry's marketing claims unquestioningly.

<span class="mw-page-title-main">American Enterprise Institute</span> American conservative think tank founded in 1938

The American Enterprise Institute for Public Policy Research, known simply as the American Enterprise Institute (AEI), is a center-right think tank based in Washington, D.C., that researches government, politics, economics, and social welfare. AEI is an independent nonprofit organization supported primarily by contributions from foundations, corporations, and individuals.

<span class="mw-page-title-main">Mark McClellan</span> American health economist (born 1963)

Mark Barr McClellan is the director of the Robert J Margolis Center for Health Policy and the Margolis Professor of Business, Medicine and Health Policy at Duke University. Formerly, he was a senior fellow and director of the Health Care Innovation and Value Initiative at the Engelberg Center for Health Care Reform at The Brookings Institution, in Washington, D.C. McClellan served as commissioner of the United States Food and Drug Administration under President George W. Bush from 2002 through 2004, and subsequently as administrator of the Centers for Medicare and Medicaid Services from 2004 through 2006.

Herbert Stein was an American economist, a senior fellow at the American Enterprise Institute, and a member of the board of contributors of The Wall Street Journal. He was the chairman of the Council of Economic Advisers under Richard Nixon and Gerald Ford. From 1974 to 1984, he was the A. Willis Robertson Professor of Economics at the University of Virginia.

<span class="mw-page-title-main">Sally Satel</span> American psychiatrist

Sally L. Satel is an American psychiatrist based in Washington, D.C. She is a lecturer at Yale University School of Medicine, a visiting professor of psychiatry at Columbia University, a senior fellow at the American Enterprise Institute, and an author.

Steven J. Milloy is a lawyer, lobbyist, author and former Fox News commentator. Milloy is the founder and editor of the blog junkscience.com.

Canada Drugs otherwise known as CanadaDrugs.com, was an online pharmacy based in Winnipeg, Manitoba.

Africa Fighting Malaria (AFM) was an NGO based in Washington D.C., United States and South Africa which stated that it "seeks to educate people about the scourge of Malaria and the political economy of malaria control". The organization generally "promotes market based solutions and economic freedom as the best ways to ensure improved welfare and longer life expectancy in poor countries", according to their financial statement. Founded in 2000 during the Stockholm Negotiations on Persistent Organic Pollutants, AFM's original focus was the promotion of a public health exemption for the insecticide DDT for malaria control. According to their website, last updated in 2011, their mission was to "make malaria control more transparent, responsive and effective by holding public institutions accountable for funding and implementing effective, integrated and country-driven malaria control policies."

The European Science and Environment Forum (ESEF), now defunct, called itself "an independent, non-profit-making alliance of scientists whose aim is to ensure that scientific debates are properly aired, and that decisions which are taken, and action that is proposed, are founded on sound scientific principles." Typically this manifested itself in questioning the science upon which environmental safety regulations are based.

Julian Morris was formerly a Research Fellow and subsequently Director of the Environment and Technology Programme of the Institute of Economic Affairs. He is also a visiting professor of Economics at the University of Buckingham. Recently, he became co-editor with Indur M. Goklany of the Electronic Journal of Sustainable Development]. Morris serves on the editorial advisory board of the academic journal, Energy & Environment.

<span class="mw-page-title-main">Henry I. Miller</span> American medical researcher and columnist

Henry I. Miller is an American medical researcher and columnist, formerly with the FDA, and from 1994 until 2018 the Robert Wesson Fellow in Scientific Philosophy and Public Policy at Stanford University's Hoover Institution, a public policy think tank located on the university's campus in California. He is an Adjunct Fellow of the Competitive Enterprise Institute.

An online pharmacy, internet pharmacy, or mail-order pharmacy is a pharmacy that operates over the Internet and sends orders to customers through mail, shipping companies, or online pharmacy web portal.

<span class="mw-page-title-main">Amir Attaran</span> Canadian lawyer and professor

Amir Attaran is a Canadian professor in both the Faculty of Law and the School of Epidemiology, Public Health and Community Medicine at the University of Ottawa.

<span class="mw-page-title-main">Ministry of National Health Services, Regulation and Coordination</span> Government of Pakistan executive body concerning health, human services

The Ministry of National Health Services, Regulation and Coordination is a cabinet level ministry of the government of Pakistan with responsibility for national public health.

Nicholas Nash Eberstadt is an American political economist. He holds the Henry Wendt Chair in Political Economy at the American Enterprise Institute (AEI), a political think tank. He is also a Senior Adviser to the National Bureau of Asian Research (NBR), a member of the visiting committee at the Harvard School of Public Health, and a member of the Global Leadership Council at the World Economic Forum.

John Holmes Makin was an American economist and resident scholar at the American Enterprise Institute. He was a consultant to the U.S. Treasury Department, the Congressional Budget Office, the International Monetary Fund, and the Bank of Japan. He specialized in international finance and financial markets, with special emphasis on both Japanese and European economies. Makin reported on the U.S. economy, writing on topics related to monetary policy, tax and budget issues, in monthly essays entitled "Economic Outlook", for the American Enterprise Institute (AEI). He was a principal at Caxton Associates from 1995 to 2010 before returning to AEI.

<span class="mw-page-title-main">Richard Vedder</span> American economist

Richard K. Vedder is an American economist, historian, author, and columnist. He is a professor emeritus of economics at Ohio University and senior fellow at The Independent Institute.

<span class="mw-page-title-main">Scott Gottlieb</span> American physician and government administrator (born 1972)

Scott Gottlieb is an American physician and investor who served as the 23rd commissioner of the Food and Drug Administration (FDA) from May 2017 until April 2019. He is presently a senior fellow at the conservative think tank the American Enterprise Institute (AEI), a partner at the venture capital firm New Enterprise Associates (NEA), a member of the board of directors of drug maker Pfizer, Inc, a member of the board of directors of Illumina, Inc., a contributor to the cable financial news network CNBC, and a frequent guest on the CBS News program Face the Nation. An elected member of the National Academy of Medicine, Gottlieb is the author of The New York Times best selling book Uncontrolled Spread on the COVID-19 pandemic and the national security vulnerabilities that it revealed.

Donald Roberts is a professor of entomology at the Uniformed Services University of the Health Sciences (USUHS) in Bethesda, Maryland, USA.

References

  1. 1 2 3 Sarvana, Adam (28 May 2009). "Bate and Switch: How a free-market magician manipulated two decades of environmental science". Natural Resources New Service. Retrieved 2 June 2009.
  2. 1 2 Bate, R; Political Economy Research Center (4 September 1998). "Letter to Greenberg, DI; Phillip Morris". Legacy Tobacco Documents Library. University of California. Bates 2065246736/6737.
  3. ↑ Bate, Roger (May 2008). "DDT Works". The Prospect Online.
  4. 1 2 3 Roger Bate CV, 4pp, 2/2009, American Enterprise Institute Scholars, retrieved 11 July 2018
  5. ↑ Email from Adam Bryan Brown 15 September 1998, 1p, Truth Tobacco Industry library UCSF
  6. ↑ Bate, Roger (28 September 1998). "Letter to Matthew Winokur".
  7. ↑ Bate R, Coticelli P, Tren R, Attaran A (2008). Awadalla P (ed.). "Antimalarial Drug Quality in the Most Severely Malarious Parts of Africa – A Six Country Study". PLOS ONE. 3 (5): e2132. Bibcode:2008PLoSO...3.2132B. doi: 10.1371/journal.pone.0002132 . PMC   2324203 . PMID   18461128. Open Access logo PLoS transparent.svg
  8. ↑ "Resisting arrest". The Economist. 15 May 2008.
  9. ↑ Bate, Roger; Ginger Zhe Jin; Aparna Mathur (2013). "In Whom We Trust: the Role of Certification Agencies in Online Drug Markets" (PDF). The B.E. Journal of Economic Analysis & Policy. 14 (1): 111–150. doi:10.1515/bejeap-2013-0085. S2CID   152966119.
  10. ↑ Bate, Roger; Ginger Zhe Jin; Aparna Mathur (July 2011). "Does price reveal poor-quality drugs? Evidence from 17 countries" (PDF). Journal of Health Economics. 30 (6): 1150–1163. doi:10.1016/j.jhealeco.2011.08.006. PMID   21917346. S2CID   14230303.
  11. ↑ Paul N. Newton, Abdinasir A. Amin, Chris Bird, Phillip Passmore, Graham Dukes, Go¨ran Tomson, Bright Simons, Roger Bate, Philippe J. Guerin, Nicholas J. White (2011). "The Primacy of Public Health Considerations in Defining Poor Quality Medicines". PLOS Medicine. 8 (12): e1001139. doi: 10.1371/journal.pmed.1001139 . PMC   3232210 . PMID   22162953.{{cite journal}}: CS1 maint: multiple names: authors list (link) Open Access logo PLoS transparent.svg
  12. ↑ "AEI – Bad Medicine in the Market". Archived from the original on 29 June 2009.
  13. ↑ "AEI – Scholars – Roger Bate". American Enterprise Institute. Retrieved 5 July 2009.
  14. ↑ Bate R, Tren R, Hess K, Attaran A (2009). "Physical and chemical stability of expired fixed dose combination artemether-lumefantrine in uncontrolled tropical conditions". Malar. J. 8 (1): 33. doi: 10.1186/1475-2875-8-33 . PMC   2649943 . PMID   19243589.
  15. ↑ "Mission".
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.